Transactions
Deal Showcase
$125 Million
Joint Bookrunner
Follow-On
February 2023
Leerink Partners Serves as Joint Bookrunner for 89bio’s (Nasdaq: ETNB) Upsized $150 Million Follow-On Offering
More Transactions
$119 Million
Joint Bookrunner
Follow-On
October 2021
$150 Million
Joint Bookrunner
Follow-On
December 2023
$35 Million
Exclusive Financial Advisor
Series C Financing Led by MultiPlan Corporation
June 2022
